Search stocks, ETFs, IPOs & more
Welcome to Multibagg AI
Log in to access personalized features
Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
Novo Nordisk's patent on semaglutide expires in India on March 20, 2026, paving the way for generic competition and a significant drop in drug prices.
Emcure Pharmaceuticals has launched Poviztra, a second brand of Novo Nordisk's semaglutide, entering India's competitive weight-loss drug market with a strategic pricing advantage.
Foreign portfolio investors withdrew ₹52,704 crore from Indian equities in early March 2026, driven by geopolitical tensions in West Asia and rising crude oil prices.
An overview of petrol and diesel prices across major Indian cities as of March 2026, detailing the factors behind daily revisions and recent price stability.
Escalating conflict in West Asia disrupts LNG shipments from Qatar, forcing India to ration gas supplies and confront significant economic and industrial challenges.
India faces LPG supply disruptions due to West Asian conflict, prompting government action to boost domestic production, curb hoarding, and expand alternative gas networks.
Indian Oil Corporation Ltd (IOCL) has increased industrial diesel prices by over 25%, citing Middle East tensions, a move set to raise operational costs for key industries.
Citi upgraded Dr Lal PathLabs from 'Sell' to 'Buy', setting a target price of ₹1,650, citing rational competition, attractive valuations, and strong growth prospects.
Natco Pharma has launched its generic semaglutide injection in India at a starting price of ₹1,290, undercutting the original Ozempic by nearly 90%.
EU leaders are considering temporary measures like tax cuts and state aid to mitigate soaring energy prices caused by the Iran war and supply disruptions.
NATCO Pharma has launched its generic semaglutide injection in India at a disruptive price point, making the diabetes and obesity treatment significantly more affordable.
HDFC Bank's stock price crashed nearly 9%, wiping out over Rs 1 lakh crore in market value following the sudden resignation of its chairman, Atanu Chakraborty.
Indian stock markets faced their steepest weekly decline in nearly four years, with the BSE Sensex falling 3.3% due to escalating Middle East tensions.
Discover today's most traded stocks by volume on NSE/BSE. Analysis on why HDFC Bank, Vodafone Idea, Yes Bank, and others saw high investor activity.
Discover today's most active stocks by traded value on NSE/BSE. Analysis of HDFC Bank, Infosys, Reliance, and others driving market volume.
Discover the top losing stocks on NSE/BSE for March 20, 2026. Analysis of why Finkurve Financial, Balaji Phosphates, and others declined today.
